In terms of valuation, CNS Pharmaceuticals Inc’s market capitalization stands at $5.85 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s ...

Ladenburg Thalmann has recently reduced CNS Pharmaceuticals Inc (CNSP) stock to Neutral rating, as announced on December 28, 2020, according to Finviz. Analyst ratings are significant because they ...